Subscribe To

Price Alert Latest News Economic Calendar News

IPSEY / Ipsen S.A. (IPSEY) Q4 2022 Earnings Call Transcript

Ipsen S.A. (OTCPK:IPSEY) Q4 2022 Results Conference Call February 9, 2023 7:45 AM ET Company Participants David Loew - CEO Aymeric Le Chatelier - CFO Howard Mayer - Head, Research and Development Conference Call Participants Elizabeth Walton - Credit Suisse Richard Vosser - JPMorgan Charles Pitman - Barclays Rosie Turner - Jefferies Thibault Boutherin - Morgan Stanley Keyur Parekh - Goldman Sachs Alistair Campbell - Royal Bank of Canada Delphine Le Louet - Societe Generale David Loew Thank you, operator. Good afternoon or good morning, everyone. Read More

Demo Live Account See Partner Details

Content Topics

Ipsen

IPSEY

2022

Earnings

Call

Transcript

ipsey

Stock

Posted: Feb 9 2023, 19:15

Author Name: Seeking Alpha

IPSEY News

By Reuters
August 16, 2023

US FDA approves Ipsen's rare bone disorder drug

The U.S. Food and Drug Administration on Wednesday approved French drugmaker Ipsen's bone disorder drug, making it the first treatment available to pa

By Seeking Alpha
February 9, 2023

Ipsen S.A. (IPSEY) Q4 2022 Earnings Call Transcript

Ipsen S.A. (OTCPK:IPSEY) Q4 2022 Results Conference Call February 9, 2023 7:45 AM ET Company Participants David Loew - CEO Aymeric Le Chatelier - CFO

By Seeking Alpha
July 30, 2022

Ipsen S.A.'s (IPSEY) CEO David Loew on Q2 2022 Results - Earnings Call Transcript

Ipsen S.A. (OTCPK:IPSEY) Q2 2022 Earnings Conference Call July 28, 2022 7:30 AM ET Company Participants David Loew – Chief Executive Officer Aymeric

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.